NCT06580405View on ClinicalTrials.gov

A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia

NANot yet recruitingINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2028

Conditions

Pre-Eclampsia, Severe

Interventions

DEVICE

KNP-1000 Apheresis System

sFlt-1 is removed from the participants' plasma through treatment.

All Listed Sponsors

lead

Kaneka Medical America LLC

INDUSTRY